| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Application for quotation of securities - EDE
|
8 Jul 2024 10:45AM |
n/a |
$0.130 |
n/a
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Proposed issue of securities - EDE
|
5 Jul 2024 12:41PM |
n/a |
$0.130 |
n/a
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
PROPOSED US PROPERTY SALES and OUTLOOK
|
24 Jun 2024 8:49AM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd is progressing with the proposed sale of its US property assets, including the planned sale of the manufacturing site in Colorado.
- The company has signed a conditional contract for the sale of its US property, with due diligence and other conditions to be finalized before completion.
- The proceeds from the proposed US property sale are expected to provide the company with working capital for ongoing operations and development.
- Eden Innovations continues to focus on its EdenCrete and EdenPlast technologies, aiming to strengthen its market position in the US and internationally.
- The company anticipates further commercial growth in the US in the coming year, driven by increased market acceptance and sales of EdenCrete.
- Management is optimistic about the outlook due to the planned property sale and ongoing product development and marketing activities.
- The announcement outlines that completion of the property transaction remains subject to satisfying key contractual conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
EdenCrete - Vail Pass Colorado Trial Update
|
18 Jun 2024 8:45AM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- EdenCrete was trialed in a bridge deck overlay on Vail Pass, Colorado, by the Colorado Department of Transportation (CDOT).
- The EdenCrete-enhanced concrete showed significantly reduced cracking compared to the control section using standard concrete.
- Durability under harsh winter conditions, including freeze-thaw cycles and de-icing chemicals, was positively noted.
- CDOT feedback indicated a marked improvement in crack resistance and overall performance of the EdenCrete section.
- Laboratory and field data supported the superior performance characteristics of EdenCrete-enhanced concrete.
- The success of the trial may lead to further adoption by CDOT and possibly other state agencies.
- Eden Innovations Ltd aims to leverage these results to expand the market for EdenCrete in infrastructure projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Non-renounceable Rights Issue Prospectus
|
14 Jun 2024 9:49AM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd is conducting a non-renounceable rights issue to raise capital.
- Eligible shareholders can apply for 1 new share for every 10 shares held, plus free attaching options.
- Funds raised will be used for working capital and ongoing product development, mainly EdenCrete and OptiBlend.
- The offer has a set timetable and clearly defined eligibility criteria.
- The prospectus details risks including dilution for non-participating shareholders and business-related risks.
- Proceeds from the issue will also support commercialization initiatives and general business operations.
- There is no minimum subscription level for the offer.
- Directors may participate in the rights issue.
- The document includes governance practices, financial information, and forward-looking statements.
- Potential impact on control of the company is outlined, including implications for major shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Proposed issue of securities - EDE
|
7 Jun 2024 5:28PM |
$0.003 |
$0.130 |
risen by
4,233.33%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Proposed issue of securities - EDE
|
7 Jun 2024 5:16PM |
$0.003 |
$0.130 |
risen by
4,233.33%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Pro-Rata Non-Renounceable Rights Issue
|
7 Jun 2024 5:07PM |
$0.003 |
$0.130 |
risen by
4,233.33%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd is conducting a pro-rata non-renounceable rights issue to raise capital.
- Eligible shareholders can subscribe for new shares with attached options.
- Funds raised will support research and development, commercialization, working capital, and corporate costs.
- The rights issue is designed to strengthen the company's financial position.
- Key products include EdenCrete® and other proprietary technologies.
- The document details offer terms, risk factors, and intended use of proceeds.
- The offer is not renounceable, meaning rights cannot be transferred or traded.
- Risk factors include market risks, operational risks, and risks related to technology commercialisation.
- Directors and company officers may participate in the rights issue.
- Timetable, application process, and investor eligibility criteria are specified.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
OptiBlend Market Update
|
31 May 2024 8:25AM |
$0.003 |
$0.130 |
risen by
5,100%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd gives a market update on its OptiBlend dual fuel technology.
- Recent purchase orders have been received from a major US power generation company.
- Demand for OptiBlend continues in the US due to high diesel prices and electricity shortages.
- The Indian market for OptiBlend has contracted significantly following recent regulatory changes.
- Eden is working to support existing customers in India despite reduced new sales.
- The company is adjusting its business strategy in response to market and regulatory changes.
- OptiBlend technology enables diesel generators to operate with a blend of natural gas and diesel.
- The update confirms continued interest and ongoing sales in the US market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
FIRST COMMERCIAL EDENCRETE Pz7 SALES -ECUADOR/USA
|
27 May 2024 8:25AM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd achieved the first commercial sales of EdenCrete Pz7 in Ecuador and the USA.
- The EDE business unit played a key role in initiating sales through partnerships and product trials.
- Successful product demonstrations and collaborations facilitated market entry.
- The sales represent a commercial breakthrough and validation of the EdenCrete product.
- Eden Innovations Ltd is expanding its footprint in North and South American markets.
- The company emphasizes ongoing strategic efforts to develop new international markets for EdenCrete.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2024 7:06PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- EdenCrete® product sales increased during the quarter, particularly in the US market.
- OptiBlend® sales continued, with additional units sold and shipped to various locations.
- The company secured new product approvals for EdenCrete® in multiple US states and increased its distribution network.
- Research and development activities focused on improving existing products and developing new applications.
- Eden filed new patent applications to strengthen its intellectual property portfolio.
- Financial report shows net cash outflows from operating activities and a closing cash balance at the end of the quarter.
- The company continues to explore new market opportunities for its products in the US and internationally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Half Year Accounts
|
29 Feb 2024 4:15PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Appendix 4D
|
29 Feb 2024 4:15PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd released its Appendix 4D for the half-year ended 31 December 2023.
- The core business is the development and sale of EdenCrete, a proprietary concrete additive.
- Sales of EdenCrete have grown, with an emphasis on expanding in the US market.
- Revenue decreased compared to the prior period, mainly due to lower grant income and slower infrastructure project activity.
- Operating expenses and R&D activities are discussed, with a focus on commercial growth and achieving product approvals.
- The report addresses working capital, cash flow management, and the status of the company as a going concern.
- Eden Innovations is actively pursuing new market opportunities and additional funding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Change of Share Registry Details
|
28 Feb 2024 12:01PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Eden Enters Conditional Joint Venture to Develop Batteries
|
21 Feb 2024 9:58AM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd enters conditional joint venture with Venture Aerospace.
- Joint venture to develop ultra-high performance solid-state batteries.
- Batteries to include Eden's carbon nanotubes for enhanced performance.
- Eden to hold 30% initial interest; Venture Aerospace to hold 70%.
- Venture Aerospace to raise up to US$10 million for working capital.
- Joint venture aims to commercialize cutting-edge battery technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
TAS: Further Extension of Loan Funding
|
12 Feb 2024 4:58PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
24 Jan 2024 9:56AM |
$0.002 |
$0.130 |
risen by
8,566.67%
|
|
EDE - Price-sensitive ASX Announcement
Full Release
Key Points
- Eden Innovations Ltd reported a net cash outflow from operating activities of A$1.547 million for the quarter ended 31 December 2023.
- Receipts from customers totaled A$646,000, while payments for R&D, product manufacturing, and staff costs were significant.
- Net cash used in investing activities was negligible, with minor expenses on property, plant, and equipment.
- Financing activities provided net cash inflow of A$400,000 driven by borrowings, with no equity issues.
- Eden’s cash and cash equivalents at the end of the quarter were A$1.469 million.
- The company has no unused financing facilities, relying on current cash and operations for funding.
- EdenCrete® international trials are ongoing with positive results anticipated to enhance market penetration.
- OptiBlend® sales in India are slow, but negotiations for large potential sales continue.
- Anticipated sale of Georgia property is expected to aid in debt reduction and operational funding.
- The company plans to improve revenue generation in the upcoming quarters through enhanced sales and operational activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Cleansing Notice - Employee Shares
|
17 Jan 2024 11:52AM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Application for quotation of securities - EDE
|
17 Jan 2024 11:36AM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Application for quotation of securities - EDE
|
16 Jan 2024 7:53PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Application for quotation of securities - EDE
|
16 Jan 2024 7:49PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Proposed issue of securities - EDE
|
16 Jan 2024 7:34PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Release of Employee Shares from Escrow
|
20 Dec 2023 5:11PM |
$0.002 |
$0.130 |
risen by
6,400%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Cleansing Notice
|
6 Dec 2023 6:42PM |
$0.003 |
$0.130 |
risen by
5,100%
|
|
| Eden Innovations Ltd (EDE) ORDINARY FULLY PAID |
Energy |
$79 |
Notification of cessation of securities - EDE
|
4 Dec 2023 12:15PM |
$0.003 |
$0.130 |
risen by
5,100%
|
|
Call 1300 880 160
Start a chat
Schedule a call
